Green Thumb Industries Inc. (GTBIF)
(Delayed Data from OTC)
$11.76 USD
+0.73 (6.62%)
Updated Aug 8, 2024 03:59 PM ET
2-Buy of 5 2
A Value A Growth A Momentum A VGM
Brokerage Reports
Green Thumb Industries Inc. [GTBIF]
Reports for Purchase
Showing records 1 - 20 ( 132 total )
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
1Q24 Strong, Buys Back Shares Improves Profitability
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Sticking to its Rule of Thumb: Prudent Capital Allocation
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Cannabis ReHash: DEA Intends to Move to Schedule 3, Investors Not Pricing It In
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
US Cannabis Sector - The Smoke has Lifted! DEA Appears Poised to Publish Schedule III Ruling
Provider: Echelon Welath Partners
Analyst: Research Department
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: February Performance and Valuations
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Strong 4Q Results; Carrying on its Merry(land) Way
Provider: Wedbush Securities Inc.
Analyst: PASCARELLI G
Company: Green Thumb Industries Inc.
Industry: Medical - Products
The Green Machine is Rolling: Results Beat on Record Sales and EBITDA, Improving Cashflow Fuels Buybacks and De-levering.
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Green Thumb Industries Inc.
Industry: Medical - Products
4Q23 Beat Setting the Bar for Sustainable FCF Cash Allocation, $21 PT
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: U.S. Cannabis 4Q23 Earnings Week I
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S